SafePennyStocks Reports 3 TOP Stocks to Watch Closely: Nanosphere, Anacor Pharmaceuticals, and Curis

Beverly Hills, CA -- (SBWIRE) -- 03/02/2013 -- http://www.SafePennyStocks.com - The US leader in microcap breakouts, offers a high quality stocks alert newsletter to investors looking for the best breakout stocks around. SafePennyStocks reports 3 penny stocks to keep an eye on for a possible bounce or more gains: NSPH, ANAC, and CRIS

The market rebounded on Friday after data released from the Institute for Supply Management revealed that its index of factory activity rose last month to 54.2, the highest since June 2011. The Dow Jones industrial average closed up 35 points, a big bounce back from an earlier loss of 116 points during the day.

1. Nanosphere (NASDAQ:NSPH) - Nanosphere develops, manufactures and markets an advanced molecular diagnostics platform, the Verigene(r) System for direct genomic and ultra-sensitive protein detection.

2. Anacor Pharmaceuticals (NASDAQ:ANAC) - Anacor Pharmaceuticals, Inc. is a biopharmaceutical company engaged in discovery, development and commercialization of novel small-molecule therapeutics derived from its boron chemistry platform.

3. Curis (NASDAQ:CRIS) - Curis, Inc. is a therapeutic drug development company focusing on cancer, neurological and dermatological disease indications, with technologies that utilize regulatory pathways that control repair and regeneration.

SafePennyStocks.com educates and shows investors the inner workings of the volatile world of penny stocks by scouring the markets for the hottest penny stocks that look poised to break out. Discover the next hidden company to profit. Sign up for the free newsletter to receive the next big report soon. Join at: http://www.SafePennyStocks.com

Sign Up at - http://www.SafePennyStocks.com for more ideas to put on your radar.

Disclosure
SafePennyStocks.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice. This press release may contain several forward looking statements. Please read our report and visit our website for complete risks and disclosures.